product Image
DiaPlexC™ Avellino Corneal Dystrophy (ACD) Genotyping Kit (Corneal Dystrophy)
Model Name
-
Series
Molecular Diagnostic (Human Gentrifyping)
Data
-
Manufacturer information
provider logo
SOLGENT

DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus

Problem with product info?
Update request
Manufacturer
SOLGENT
Brand
-
SKU
125226
Product Name
DiaPlexC™ Avellino Corneal Dystrophy (ACD) Genotyping Kit (Corneal Dystrophy)
Model Name
-
Size
-
Weight
-
Product Details

DiaPlexC™ Avellino Corneal Dystrophy (ACD) Genotyping Kit

Multiplex allele-specific PCR based assay system for the genotyping of the ACD gene SNP related to avellino corneal dystrophy

CE-IVD


ACD is a hereditary disease and one of the corneal dystrophies involving the formation of corneal opacities on different Layers of the corneal stroma, which leads to significant impairment of the corneal transparency and refraction. ACD is caused by the formation and deposition of abnormal hyaline protein which is generated by the replacement of histidine from arginine due to the mutation of cordon 124 (exon 4) in the βigh 3 gene. The deposited abnormal hyaline protein is usually known as kerato-epithelin and forms a granular, lattice precipitate causing visual impairment and might lead to blindness if it remains undiagnosed. Genetic mutation is highly accelerated after laser eye surgery in those people who have ACD, causing a worsening in vision rather than improvement after surgery. The awareness of ACD has developed across the world, with some opticians now refusing access to LASIK in patients with ACD due to the harmful effects the procedure has on patients.





Specification


DiaPlexC™ Avellino Corneal Dystrophy (ACD) PCR Genotyping Kit
Detection targetSNP of R124 (βigh3 coding gene codon 124, exon4)
RegistrationCE-IVD
Detection technologyConventional (End-point) Multiplex PCR
Specimen typeBlood, Buccal epithelial cell, Hair (root)
Compatible instruments*ABI Veriti thermal Cycler (Applied Biosystems) recommended
PCR running time~ 1hr 30 min




Features

- HotStart PCR system : Ultra high specific and sensitive result

- UDG system : No carryover contamination

- Multiplex PCR : Multiple targets in a single reaction

- Reliable system : Automatic Internal control ( DiaPlex C™)

- Positive control included

- Easy-to-use master mix

- CE certification





Experimental


LaneInterpretation (detection)
1ACD (G/G homozygote, normal)
2ACD (G/A heterozygote, mutant)
3ACD (A/A homozygote, mutant)
4Required re-experiment




Citation&Papers

Kocak-Atlintas AG, Kocak-Midillioglu I, Akarsu AN, Duman S.

βigh gene analysis in the different diagnosis of corneal dystrophies. Cornea 2001; 20: 64-8.

Klintworth GK.

Advances in the molecular genetics of corneal dystrophies. Am J phthalmol 1999; 128: 747-54.

Konishi M, Mashima Y, Nakamura Y, et al.

Granular-lattice (Avellino) corneal dystrophy in Japanese patients. Cornea 1997; 16: 635-8.






Ordering information

TechnologyCat. No.ProductContents



Conventional (End-point) PCR
SHG06-K020
(20 reaction)


DiaPlexC™ Avellino Corneal Dystrophy (ACD)
Genotyping Kit
2X Multiplex PCR Smart mix (with UDG) (ACD)
Primer Mixture (ACD)
Standard Marker (ACD)
Wild type Control (ACD)
Mutant type Control (ACD)
Nuclease free Water
SHG06-K100
(100 reaction)



More products
SOLGENT
DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
For the past 19 years, SolGent grown as a company specialized in human molecular diagnostics projects. In celebration of its 20th anniversary, the company announced its vision of a new start, “SolGent 2.0” and is growing as a bio leader in the 4th Industrial Revolution. Sturdily amassed genome analysis technology and molecular diagnostic technology have become the prominent foundation of the molecular diagnostic market, and SolGent supply products and services with the highest quality to more than 25 countries including domestic research institutes, examination centers, medical institutions and universities. In particular, as “precision medicine,” which analyzes genomes to prevent and predict diseases, becomes a new medical paradigm, SolGent develops and supplies various genome analysis services including for cancer, and expands and applies these services to agricultural products to build the AG-BIO platform. Based on its innovative technology, SolGent develops NADPH coenzyme fixed quantity measurement products DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
Inquiry